Blue Zone Therapeutics
Biotechnology Research • 
University, Florida, United States • 1-10 Employees
Company overview
| Headquarters | University, Florida, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Gene Therapy, Chronic Disorders, Age Related Diseases, Metabolic Disturbances, Veterinary Application |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at Blue Zone Therapeutics
Aurélie Joly-Amado
Chief Executive Officer
About Blue Zone Therapeutics
Blue Zone Therapeutics is dedicated to creating breakthrough treatments for age-related diseases in pets, helping them live longer, healthier lives. By combining cutting-edge science with deep veterinary insight, we’re redefining what’s possible in companion animal care.
$
Blue Zone Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Blue Zone Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Blue Zone Therapeutics has never raised funding before.
Canada
Spain
Morocco
Australia
United Kingdom
Frequently asked questions
Blue Zone Therapeutics is located in University, Florida, US.
Blue Zone Therapeutics was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.
Blue Zone Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
